pre-ipo
Stage
1
Investors
About
Biohaven is a clinical-stage biopharmaceutical company that develops and commercializes treatments for immunology, neuroscience, oncology, and obesity, with approved therapies for migraine and a pipeline of novel drugs addressing unmet medical needs.
Explore Biohaven's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.